---
id: 044
title: Metronidazole Spectrum and Clinical Uses
category: antimicrobials
subcategory: metronidazole
tags: [metronidazole, anaerobes, C-difficile, BV, trichomoniasis, giardia, BAG-ATP]
difficulty: medium
---

## Question

What is metronidazole's spectrum of activity and key clinical uses? Use the **BAG-ATP** mnemonic.

## Answer

**BAG-ATP mnemonic for metronidazole coverage:**

- **B**acteroides (anaerobic bacteria)
- **A**moeba (*Entamoeba histolytica*)
- **G**iardia
- **A**naerobes (Gram-negative and Gram-positive)
- **T**richomonas
- **P**revotella/Peptostreptococcus

### **Spectrum:**

| Organism Type | Activity | Examples |
|---------------|----------|----------|
| **Anaerobic bacteria** | Excellent | *Bacteroides fragilis*, *Prevotella*, *Fusobacterium*, *Peptostreptococcus* |
| **Protozoa** | Excellent | *Trichomonas*, *Giardia*, *Entamoeba* |
| ***C. difficile*** | Good | Oral for CDI |
| **NO activity** | None | Aerobic bacteria, fungi, viruses |

### **Key Clinical Uses:**

| Indication | Dose | Duration | Notes |
|------------|------|----------|-------|
| ***C. difficile* (mild-moderate)** | 500mg PO TID | 10 days | Second-line (vancomycin preferred) |
| **Bacterial vaginosis** | 500mg PO BID or 0.75% gel | 5-7 days | *Gardnerella* |
| **Trichomoniasis** | 2g PO × 1 or 500mg BID | 1 day or 7 days | Treat partners |
| **Giardiasis** | 250-500mg PO TID | 5-7 days | Alternative: tinidazole |
| **Intra-abdominal infections** | 500mg IV q8h | Variable | + aerobic coverage |
| **Brain abscess** | 500mg IV q8h | 4-8 weeks | Anaerobic coverage |
| ***H. pylori* eradication** | 500mg PO BID | 14 days | Triple/quadruple therapy |

## Key Points

### **Mechanism:**
- Prodrug activated by anaerobic metabolism
- Forms nitroso radicals → DNA strand breaks
- Concentration-dependent killing

### **Does NOT Cover:**
- **Aerobic bacteria** (no activity)
- Non-spore-forming Gram-positive anaerobes (*Actinomyces*, *Propionibacterium*, *Lactobacillus*)

### **Clinical Pearls:**
- Good **CNS penetration** (brain abscesses)
- PO = IV bioavailability (~100%)
- Use IV only if cannot tolerate PO

## Sources

- [StatPearls NBK539728: Metronidazole]
- [PMC4550478: Metronidazole-triazole Conjugates Activity]

## Media

N/A
